Thrombogenic risk factors for cardiovascular disease in dialysis patients

被引：11

作者：

Culleton, BF ^{[1
]}

Wilson, PWF ^{[1
]}

机构：

[1] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA

来源：

SEMINARS IN DIALYSIS | 1999年 / 12卷 / 02期

关键词：

D O I：

10.1046/j.1525-139X.1999.00002.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：117 / 125

页数：9

共 142 条

[91]

Mendall MA, 1996, BRIT MED J, V312, P1061

[92]

Mezzano D, 1996, THROMB HAEMOSTASIS, V76, P312

[93] INCREASED RENAL-ALLOGRAFT THROMBOSIS IN CAPD PATIENTS [J].

MURPHY, BG ;

HILL, CM ;

MIDDLETON, D ;

DOHERTY, CC ;

BROWN, JH ;

NELSON, WE ;

KERNOHAN, RM ;

KEANE, PK ;

DOUGLAS, JF ;

MCNAMEE, PT .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) :1166-1169

[94] Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women [J].

Nguyen, TT ;

Ellefson, RD ;

Hodge, DO ;

Bailey, KR ;

Kottke, TE ;

AbuLebdeh, HS .

CIRCULATION, 1997, 96 (05) :1390-1397

[95] A clinical study to assess the effect of heparin in dialyzer rinsing solutions [J].

Opatrny, K ;

Bouda, M ;

Kohoutkova, L ;

Vit, L ;

Sefrna, F .

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1997, 20 (02) :112-118

[96] HEMOCOMPATIBILITY IN HEMODIALYSIS AND ERYTHROPOIETIN THERAPY [J].

OPATRNY, K ;

VIT, L ;

OPATRNA, S ;

POLAKOVIC, V ;

SEFRNA, F ;

SULKOVA, S ;

OPATRNY, K .

ARTIFICIAL ORGANS, 1995, 19 (08) :814-820

[97]

Opatrny K, 1998, AM J NEPHROL, V18, P186

[98]

OPATRNY K, 1995, NIEREN HOCHDRUCK, V24, P324

[99]

OPATRNY K, 1991, J NEPHROL, V4, P233

[100] COMPREHENSIVE STUDY OF HEMOSTASIS IN CHRONIC UREMIA [J].

PANICUCCI, F ;

SAGRIPANTI, A ;

PINORI, E ;

VISPI, M ;

LECCHINI, L ;

BARSOTTI, G ;

GIOVANNETTI, S .

NEPHRON, 1983, 33 (01) :5-8

← 5 6 7 8 9 10 11 12 13 14 →